Dennis J Purcell - Net Worth and Insider Trading
Dennis J Purcell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis J Purcell owns 12 companies in total, including Loxo Oncology Inc (LOXO) , Syros Pharmaceuticals Inc (SYRS) , and Agile Therapeutics Inc (AGRX) among others .
Click here to see the complete history of Dennis J Purcell’s form 4 insider trades.
Insider Ownership Summary of Dennis J Purcell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LOXO | Loxo Oncology Inc | 2018-07-10 | 10 percent owner |
| SYRS | Syros Pharmaceuticals Inc | 2016-06-29 | 10 percent owner |
| AGRX | Agile Therapeutics Inc | 2014-05-23 | 10 percent owner |
 | | 2016-03-30 | 10 percent owner |
| | 2013-12-06 | 10 percent owner |
| | 2015-12-09 | 10 percent owner |
| | 2015-04-23 | 10 percent owner |
| | 2015-04-14 | 10 percent owner |
| | 2015-01-27 | 10 percent owner |
| | 2014-01-23 | 10 percent owner |
| | 2012-02-13 | 10 percent owner |
| | 2012-02-07 | 10 percent owner |
Dennis J Purcell Trading Performance
Dennis J Purcell Ownership Network
Ownership Network List of Dennis J Purcell
Ownership Network Relation of Dennis J Purcell
Dennis J Purcell Owned Company Details
What does Loxo Oncology Inc do?
Who are the key executives at Loxo Oncology Inc?
Dennis J Purcell is the 10 percent owner of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .
Loxo Oncology Inc (LOXO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Loxo Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Dennis J Purcell is the 10 percent owner of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Dennis J Purcell made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Chee Conley .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Agile Therapeutics Inc do?
Who are the key executives at Agile Therapeutics Inc?
Dennis J Purcell is the 10 percent owner of Agile Therapeutics Inc. Other key executives at Agile Therapeutics Inc include Chief Financial Officer Scott M Coiante , Chief Commercial Officer Amy Welsh , and director & Chief Executive Officer Alfred Altomari .
Agile Therapeutics Inc (AGRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agile Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ViewRay Inc do?
Who are the key executives at ViewRay Inc?
Dennis J Purcell is the 10 percent owner of ViewRay Inc. Other key executives at ViewRay Inc include SVP & General Counsel Sanket Shah , 10 percent owner Farhad Fred Ebrahimi , and Chief Commercial Officer Paul Jr Ziegler .
ViewRay Inc (VRAYQ) Insider Trades Summary
Over the past 18 months, Dennis J Purcell made no insider transaction in ViewRay Inc (VRAYQ). Other recent insider transactions involving ViewRay Inc (VRAYQ) include a net sale of 110,324 shares made by B Kristine Johnson , a net sale of 8,203,610 shares made by Farhad Fred Ebrahimi , and a net sale of 2,408,747 shares made by Scott William Drake .
In summary, during the past 3 months, insiders sold 0 shares of ViewRay Inc (VRAYQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,487,227 shares of ViewRay Inc (VRAYQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,487,227 shares.
ViewRay Inc (VRAYQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
ViewRay Inc Insider Transactions
- Download to Excel(.xls)
What does Asensus Surgical Inc do?
Who are the key executives at Asensus Surgical Inc?
Dennis J Purcell is the 10 percent owner of Asensus Surgical Inc. Other key executives at Asensus Surgical Inc include Chief Technology Officer Fernando Anthony C. J. , EVP & Chief Financial Officer Rampertab Shameze , and Interim CFO Brett Farabaugh .
Asensus Surgical Inc (ASXC) Insider Trades Summary
Over the past 18 months, Dennis J Purcell made no insider transaction in Asensus Surgical Inc (ASXC). Other recent insider transactions involving Asensus Surgical Inc (ASXC) include a net sale of 0 shares made by Starling William N Jr ,
In summary, during the past 3 months, insiders sold 0 shares of Asensus Surgical Inc (ASXC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18,134 shares of Asensus Surgical Inc (ASXC) were sold and 18,134 shares were bought by its insiders, resulting in a net sale of 0 shares.
Asensus Surgical Inc (ASXC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Asensus Surgical Inc Insider Transactions
- Download to Excel(.xls)
What does T2 Biosystems Inc do?
Who are the key executives at T2 Biosystems Inc?
Dennis J Purcell is the 10 percent owner of T2 Biosystems Inc. Other key executives at T2 Biosystems Inc include 10 percent owner Cr Group L.p. , 10 percent owner Crg Partners Iii (cayman) Unlev Aiv I L.p. , and 10 percent owner Crg Partners Iii (cayman) Lev Aiv I L.p. .
T2 Biosystems Inc (TTOO) Insider Trades Summary
Over the past 18 months, Dennis J Purcell made no insider transaction in T2 Biosystems Inc (TTOO). Other recent insider transactions involving T2 Biosystems Inc (TTOO) include a net sale of 48,345,798 shares made by Cr Group L.p. , and a net sale of 55 shares made by David B Elsbree .
In summary, during the past 3 months, insiders sold 55 shares of T2 Biosystems Inc (TTOO) in total and bought 0 shares, with a net sale of 55 shares. During the past 18 months, 483,513 shares of T2 Biosystems Inc (TTOO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 483,513 shares.
T2 Biosystems Inc (TTOO)'s detailed insider trading history can be found in Insider Trading Tracker table.
T2 Biosystems Inc Insider Transactions
- Download to Excel(.xls)
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Dennis J Purcell is the 10 percent owner of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Dennis J Purcell made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,679 shares made by Eric Warren , a net sale of 4,202 shares made by Joanne M. Foody , and a net sale of 14,550 shares made by Sheldon L. Koenig .
In summary, during the past 3 months, insiders sold 17,476 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 17,476 shares. During the past 18 months, 26,431 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 26,431 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Cidara Therapeutics Inc do?
Who are the key executives at Cidara Therapeutics Inc?
Dennis J Purcell is the 10 percent owner of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , Chief Medical Officer Taylor Sandison , and director & President & CEO Jeffrey Stein .
Cidara Therapeutics Inc (CDTX) Insider Trades Summary
Over the past 18 months, Dennis J Purcell made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 30,407 shares made by Leslie Tari , a net sale of 40,379 shares made by Taylor Sandison , and a net purchase of 58,000 shares made by Jeffrey Stein .
In summary, during the past 3 months, insiders sold 1,833 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 1,833 shares. During the past 18 months, 7,751 shares of Cidara Therapeutics Inc (CDTX) were sold and 11,000 shares were bought by its insiders, resulting in a net purchase of 3,249 shares.
Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cidara Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Aravive Inc do?
Who are the key executives at Aravive Inc?
Dennis J Purcell is the 10 percent owner of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .
Aravive Inc (ARAV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aravive Inc Insider Transactions
- Download to Excel(.xls)
What does ZELTIQ Aesthetics Inc do?
Who are the key executives at ZELTIQ Aesthetics Inc?
Dennis J Purcell is the 10 percent owner of ZELTIQ Aesthetics Inc. Other key executives at ZELTIQ Aesthetics Inc include director & 10 percent owner Andrew N Schiff , SVP & Research and Development Bradley Hauser , and SVP of Global Marketing Danika R Harrison .
ZELTIQ Aesthetics Inc (ZLTQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ZELTIQ Aesthetics Inc (ZLTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ZELTIQ Aesthetics Inc (ZLTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ZELTIQ Aesthetics Inc (ZLTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
ZELTIQ Aesthetics Inc Insider Transactions
- Download to Excel(.xls)
What does ADMA Biologics Inc do?
Who are the key executives at ADMA Biologics Inc?
Dennis J Purcell is the 10 percent owner of ADMA Biologics Inc. Other key executives at ADMA Biologics Inc include director & President and CEO Adam S Grossman , EVP & CFO Brian Lenz , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
ADMA Biologics Inc (ADMA) Insider Trades Summary
Over the past 18 months, Dennis J Purcell made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 1,486,717 shares made by Adam S Grossman , a net sale of 1,500,000 shares made by Steve Elms , and a net sale of 35,000 shares made by Young Kwon .
In summary, during the past 3 months, insiders sold 856,256 shares of ADMA Biologics Inc (ADMA) in total and bought 0 shares, with a net sale of 856,256 shares. During the past 18 months, 5,039,794 shares of ADMA Biologics Inc (ADMA) were sold and 155,000 shares were bought by its insiders, resulting in a net sale of 4,884,794 shares.
ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
ADMA Biologics Inc Insider Transactions
- Download to Excel(.xls)
What does Melinta Therapeutics Inc do?
Who are the key executives at Melinta Therapeutics Inc?
Dennis J Purcell is the 10 percent owner of Melinta Therapeutics Inc. Other key executives at Melinta Therapeutics Inc include director & Chief Executive Officer John Johnson , director & See Remarks Daniel Mark Wechsler , and Chief Commercial Officer John Temperato .
Melinta Therapeutics Inc (MLNTQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Melinta Therapeutics Inc (MLNTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Melinta Therapeutics Inc (MLNTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Melinta Therapeutics Inc (MLNTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Melinta Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
Dennis J Purcell Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis J Purcell. You might contact Dennis J Purcell via mailing address: Auxilium Pharmaceuticals, Inc., 160 West Germantown Pike, Norristown Pa 19401.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
